Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

AMPH Amphastar Pharmaceuticals Inc

45,46

0,91 (2,04%)

23 Nov 2024 - Geschlossen

Verzögert um 15 Minuten

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Amphastar Pharmaceuticals (NASDAQ:AMPH)
Historical Stock Chart
Von Okt 2024 bis Nov 2024

Click Here for more Amphastar Pharmaceuticals Charts.

Amphastar Pharmaceuticals (NASDAQ:AMPH)
Historical Stock Chart
Von Nov 2023 bis Nov 2024

Click Here for more Amphastar Pharmaceuticals Charts.

News Amphastar Pharmaceuticals Inc

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 14 November 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 13 November 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Dienstag 12 November 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 9 November 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 7 November 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Mittwoch 6 November 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 6 November 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 17 September 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 17 September 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 7 September 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Donnerstag 5 September 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Freitag 30 August 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere Amphastar Pharmaceuticals Inc News-Artikel

Health Care Select Sector

BNP Paribas (QX)

JP Morgan Chase

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen